The Rising Prevalence Of COPD To Boost Spirometers Market Growth

Spirometers Market
Spirometers Market

The Spirometers Market is Segmented by Type (Hand-Held, and Table-Top), Technology (Volume Measurement, and Flow Measurement), Application (Asthma, COPD, Cystic Fibrosis, and Others), End-User (Hospitals and Clinics, and Home Healthcare) and by Region (Europe, North America, Asia Pacific, Africa, Latin America and Middle East) - Size, Share, Outlook, and Opportunity Analysis, 2023 – 2030

The global Spirometers Market is estimated to be valued at US$ 1.0 billion in 2022 and is expected to exhibit a CAGR of 10.20 % over the forecast period (2023-2030), as highlighted in a new report published by Coherent Market Insights.

Market Overview:

A spirometer is a medical equipment that evaluates the quantity of air one is capable to inhale and exhale. It also traces the timespan it takes for the individual to breathe out completely post one is taking a deep breath. A spirometry test necessitates one to breathe into a catheter linked to a machine known as a spirometer.

Competitive Landscape:

Key Players involved in the growth of the global Spirometers for Market are Koninklijke Philips N.V., MGC Diagnostics Corporation, KoKo PFT, NDD Medical Technologies and ICU Medical, Inc.

Market Key Drivers:

The rising prevalence of COPD is expected to augment the growth of global Spirometers Market. For instance, as per WHO, above 65 million suffer from COPD across the globe.

Technical developments and the rising convenience and convenience of operation of equipment are projected to boost the growth of the global Spirometers for Market. For instance, in March 2021, the AioCare was launched by Vyaire Medical in above 15 countries, involving Australia and other regions.

Covid-19 Impact Analysis:

The COVID-19 outbreak has adversely affected the growth of the global spirometer for market as there was a decline in the analysis and cure of individuals suffering from respiratory disorders. For instance, as per Elsevier Public Health Emergency, in September 2021, it has been monitored that the usage of spirometry is limited to immunocompromised individuals for urgent therapeutics only, such as bone marrow grafts, lung implantation, and pre-chemotherapy therapeutics.

Key Takeaways:

The global Spirometers Market is anticipated to exhibit a CAGR of 10.20 % during the forecast period due to increasing asthma cases and the rising number of smokers. For instance, as per WHO, above 80% of the global 1.3 billion tobacco consumers live in low- and middle-income regions.

Among regions, North America, Europe, and Asia Pacific are expected to witness robust growth in the global spirometer for market due to rise in cases of COPD, increasing asthma cases, increasing smokers and rising collaborations and partnerships. For instance, as per AAFA, in April 2022, around 1 in 13 Americans suffer from asthma, which is around 25 million people in U.S.

Comments

Post a Comment

Popular posts from this blog

Sarcopenia Treatment; Training and Physical Exercise Is Key to Counteract Sarcopenia

Image
Sarcopenia Treatment A primary Sarcopenia Treatment is exercise. Researchers have identified resistance training as the specific form of exercise that is most beneficial to individuals with sarcopenia. At present, resistance exercise, protein supplementation, and vitamin D have been established as the basic treatment of sarcopenia. Recent clinical trials on sarcopenia therapies such as physical exercise, nutraceutical, and pharmaceutical interventions have revealed that exercise is the only effective strategy shown to alleviate sarcopenia. Sarcopenia refers to a loss of muscle mass specifically related to aging. It's normal to lose some muscle mass as people age. Sarcopenia has been defined as an age-related, involuntary loss of skeletal muscle mass and strength. Although aging is the main cause of sarcopenia, some other factors contribute to the loss of muscle mass. Getting little or no physical activity on a regular basis puts people at an increased risk of developing sarcopenia
Read more

Bioresorbable Implants Can Also Help To Prevent Complications And Speed Up The Recovery Process

Image
Bioresorbable Implants Medical implants, either passive for structural support or for diagnosis and therapy with active electronics, are widely used in surgical applications. Although they have shown long-term biocompatibility, their removal imposes physical, biological and economical burdens on patients. To overcome this drawback, implantable devices exhibiting biodegradation in the body have been developed. These implants disappear inside the body after a certain time of use, and can be replaced with natural bone. The resorption of Bioresorbable Implants is driven by hydrolysis of the bonds linking their monomers. The amorphous portions of the polymer degrade first, while the crystalline regions remain intact and provide most of their mechanical strength. The monomers are then broken down into lactic and glycolic acids, which are converted to pyruvate and then processed through the citric acid cycle into water and carbon dioxide. The Bioresorbable Implants Market was valued at US$
Read more

Increasing Developments by Key Players Are Expected To Augment the Growth of the Global Digital Pathology Market

Image
 Digital Pathology Digital Pathology Market , by Product Type (Image Analysis Software, Scanner {Bright Field Scanner, Fluorescence Scanner}, Services {Installation & Integration, Maintenance Services, Consulting Services}), by Therapeutic Area (Oncology, Hematology, Autoimmune Disorder, Dermatology, and Others), by Technology (Immunohistochemistry, ISH & FISH, Immunofluorescence and others) End User (Pharmaceutical & Biotechnology Companies, Diagnostic Labs, Hospital Laboratories, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030. The global Digital Pathology Market is anticipated to reach an estimated value of US$ 884.4 million in 2023 and is projected to grow at a CAGR of 12.2% from 2023 to 2030. Market Overview: Digital pathology refers to the practice of digitizing glass slides containing tissue samples and analyzing them using digital imaging technology
Read more